Back to Search
DR. DAVIDE MARCO CROCI MD
MD
Neurological Surgery Physician
NPI: 1699392738IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
ME158693(FL)
Education
OTHER
Class of 2013
Research & Publications (20)
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.
PMID 19127265·Br J Cancer·2009
3-trial
Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
PMID 19453289·Clin Chem Lab Med·2009
5-case
Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.
PMID 19668220·Nat Immunol·2009
7-preclinical
Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
PMID 18553460·J Cell Biochem·2008
8-other
The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation.
PMID 17984174·FASEB J·2008
8-other
Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway.
PMID 18261236·Retrovirology·2008
8-other
Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.
PMID 18081536·Expert Opin Biol Ther·2008
6-review
A new function of microtubule-associated protein tau: involvement in chromosome stability.
PMID 18583940·Cell Cycle·2008
8-other
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death.
PMID 17589510·Nat Immunol·2007
7-preclinical
Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines.
PMID 18196869·Oncol Res·2007
8-other
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.
PMID 17571260·Cancer Immunol Immunother·2007
6-review
Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with glioma.
PMID 16357523·Cancer Biol Ther·2006
8-other
The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
PMID 16730950·Epilepsy Res·2006
8-other
Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas.
PMID 16760646·Cancer Biol Ther·2006
8-other
Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.
PMID 16981197·Glia·2006
8-other
Pravastatin in vivo reduces mononuclear cell migration through endothelial monolayers.
PMID 16998730·Neurol Sci·2006
4-observational
In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas.
PMID 17294805·Oncol Res·2006
8-other
In vitro effects of topotecan and ionizing radiation on TRAIL/Apo2L-mediated apoptosis in malignant glioma.
PMID 15719269·J Neurooncol·2005
8-other
Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
PMID 15730534·Epilepsia·2005
4-observational
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
PMID 16193381·J Neurooncol·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 515 E 100 S STE 200
SALT LAKE CITY, UT 84102 - Phone
- (801) 581-2401
Quick Facts
- NPI
- 1699392738
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile